-
NON-ALCOHOLIC STEATOHEPATITIS (NASH)
At Anshi, we are committed to pioneering breakthroughs in NASH therapeutics.
-
OBESITY
Anshi is committed to developing novel pharmaceuticals that address the underlying causes of obesity.
-
OSTEOPOROSIS
We are dedicated to advancing the field of bone health by developing treatments that not only strengthen bones but also improve overall bone health.